Tien Liang BioTech Co., Ltd. (TPEX:4127)
Taiwan · Delayed Price · Currency is TWD 35.85
-0.45 (-1.24%)
Mar 6, 2026, 9:44 AM CST
Tien Liang BioTech Market Cap
Tien Liang BioTech has a market cap or net worth of 1.66 billion as of March 5, 2026. Its market cap has decreased by -9.48% in one year.
Market Cap
1.66B
Enterprise Value
2.09B
Revenue
467.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
35.85
Market Cap Chart
Since July 19, 2005, Tien Liang BioTech's market cap has increased from 767.70M to 1.66B, an increase of 116.37%. That is a compound annual growth rate of 3.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 1.64B | 15.65% |
| Dec 31, 2025 | 1.42B | -25.30% |
| Dec 31, 2024 | 1.90B | 186.21% |
| Dec 29, 2023 | 663.52M | -6.15% |
| Dec 30, 2022 | 706.99M | 4.39% |
| Dec 30, 2021 | 677.25M | 32.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Johnson Chemical Pharmaceutical Works | 2.55B |
| Golden Biotechnology | 2.30B |
| TSH Biopharm Corporation | 2.09B |
| GeneFerm Biotechnology | 1.78B |
| InnoPharmax | 1.67B |
| Winston Medical Supply | 1.53B |
| DV Biomed | 1.42B |
| Excelsior Biopharma | 1.27B |